HALAVEN 0.44 mg/ml solution for injection clinical trials

ERibulin in Advanced Solitary fibrous tumor, an ItaliaN sarcoma Group phase II study (ERASING)

This study is testing a new medicine, Halaven, for a type of cancer called advanced solitary fibrous tumour. Researchers want to see how well it shrinks tumours and if it helps people live longer and feel better. It's a Phase II study, meaning it's still being tested.